"CHRISTUS Mother Frances Hospital in Tyler, Texas offers world-class medical services and treatments including emergency medicine and trauma care, urgent care, heart care, surgery, birth services, pediatrics, family medicine, and more."

During the past decade, Trinity Mother Frances Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Trinity Mother Frances Hospital" #1 sponsor was "Abbott Medical Devices" with 1 trials, followed by "Baim Institute for Clinical Research" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Daniel Benjamin" with 1 trials sponsored and "Procter and Gamble" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Trinity Mother Frances Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Trinity Mother Frances Hospital" are "Coronary Artery Disease" (3 trials), "Acute Myocardial Infarction" (1 trials), "Atherosclerosis" (1 trials), "Covid19" (1 trials) and "Lumbar Spinal Stenosis" (1 trials). Many other conditions were trialed in "Trinity Mother Frances Hospital" in a lesser frequency.

Most popular intervention types in "Trinity Mother Frances Hospital" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System" (1 trials), "Abatacept" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Infliximab" (1 trials) and "MILD" (1 trials). Other intervention names were less common.

The vast majority of trials in "Trinity Mother Frances Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Trinity Mother Frances Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Trinity Mother Frances Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Trinity Mother Frances Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".